onlinemedmarket.net

Your reliable supplier of generic medications.

Check yourbonu$
Site search:
Obvious advantage Tell a friend and get discount! Want to give it a try?
Categories list

Generic Terbinafine - Lamisil, Lamisil Cream

Search by letter:ABCDEFGHIJKLMNOPQRSTUVWXYZ
Lamisil

Generic Lamisil

Terbinafine 250mg

Generic Lamisil is an antifungal antibiotic. It is used to treat infections caused by fungus that affect the fingernails or toenails.
More info »

$2.58 Buy now!
Lamisil Cream

Generic Lamisil Cream

Terbinafine 1% 10g

Generic Lamisil Cream is used for treating fungal infections of the fingernails and toenails.
More info »

$3.00 Buy now!
Choose Your language:
Social bookmarks:
Testimonials

Your email was addressed as a survey and the only link was the one I am responding to now.
To question #1; Did I receive the medication shipment as ordered?
The answer is yes, and I was impressed with the time in which it was delivered to my home; only 10 days!
To question #2; did the medication meet my expectations?
Again the answer is yes! I was also impressed with your website which explains everything about ordering outside the U.S., quality of the medication made at the India labs, number(s) to call if the shipment is held up in Customs, and the ease in placing the order. - Dave

Special Offer!

  • Health Canada Grants Apricus Biosciences Pre-NDS Meeting for MycoVa(TM) for ... - MarketWatch (press release)

    Health Canada Grants Apricus Biosciences Pre-NDS Meeting for MycoVa(TM) for .

  • New Nd:YAG laser delivery option manages onychomycosis, study shows - ModernMedicine

    New Nd:YAG laser delivery option manages onychomycosis, study showsModernMedicineThough they have a proven efficacy, oral antifungal therapies used in onychomycosis such as terbinafine (Lamisil, Novartis) and itraconazole (Sporanox, Janssen) can have significant adverse events, including potential hepatic toxicity.

  • Novartis to buy Fougera Pharma for $1.5 bln - Stock Market Digital

    Novartis to buy Fougera Pharma for $1.

  • Interview With The President And CEO: Apricus Biosciences, Inc. (APRI ... - The Wall Street Transcript

    Interview With The President And CEO: Apricus Biosciences, Inc.

  • 붙이는 조백선 치료제 3상 임상서 효과 미흡 - 메디파나뉴스

    붙이는 조백선 치료제 3상 임상서 효과 미흡메디파나뉴스일본 히사미츠제약이 조백선 치료제로 개발을 추진하고 있는 'HTU-520'(terbinafine)이 3상 임상시험에서 기대한 만큼의 효과를 얻지 못한 것으로 나타났다.

bookmark Bookmark this site
Subscribe to the News
Trusted. Rx approved.